Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

Clinical trial NCT04990479 · TERMINATED

Trial details

NCT number: NCT04990479
Sponsor: Nouscom SRL
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)Non-Small-Cell Lung Carcinoma

Start date: 2021-06-11
Primary completion: 2024-03-05
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.